Indication
Ovarian Sarcoma
1 clinical trial
2 products
1 drug
Clinical trial
Phase I Randomized Study of MAGE-12 Peptide Vaccine in Patients With Refractory Metastatic Cancer Expressing MAGE-12 AntigenStatus:
Drug
interleukin-2Product
MAGE-12Product
Montanide ISA-51